Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price on Feb 6, 2025

Revance Therapeutics Employees

Revance Therapeutics had 597 employees as of December 31, 2023. The number of employees increased by 63 or 11.80% compared to the previous year.

Employees
597
Change (1Y)
63
Growth (1Y)
11.80%
Revenue / Employee
$430,394
Profits / Employee
-$308,943
Market Cap
383.05M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20235976311.80%
Dec 31, 2022534397.88%
Dec 31, 2021495255.32%
Dec 31, 2020470277143.52%
Dec 31, 20191932313.53%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro